OMS Trace Analytics

Deliver personalized patient care with the only histologically validated, objective, and quantitative CTA-based arterial analysis software. Utilize ground-truth histology to visualize the source of myocardial ischemia and inform heart attack and stroke risk. Heart attack and stroke are primarily caused by non-obstructive, but unstable plaque in the arteries that goes undiagnosed and untreated. Current non-invasive testing cannot visualize the biology deep inside artery walls where heart disease develops. Elucid is harnessing scientific imaging and artificial intelligence to enable quick, accurate, noninvasive diagnoses and precise treatment of cardiovascular disease to enable better patient outcomes. Assess plaque composition with histology-validated software. Quantify heart attack and stroke risk with greater accuracy. Visualize a comprehensive and objective view of arterial disease to enable personalized treatment plans before a patient ever enters the hospital.

Every year, cardiovascular diseases claim over 20 million lives worldwide. Many of these deaths could be prevented with early detection. Yet, the global healthcare system is overwhelmed, and limited by human capacity for detailed analysis. That's where AIATELLA steps in. Our groundbreaking AI-powered image analysis solution transforms the landscape of cardiovascular diagnostics. By automating manual measurements of vasculature in a quantified way and using historical data, we drastically cut down on the time, cost, and level of expertise needed, significantly expanding the capacity for critical imaging. AIATELLA's solution improves the speed, accuracy, and precision of diagnostics, delivering measurements and disease-progression analysis in seconds instead of hours. By improving the speed, accuracy, and variability in the analysis we are enabling the doctors to spend more time with patients and enabling true preventative and personalized medicine for all.